NC Healthcare (01518) released its annual performance, reporting a net loss of 115 million yuan attributable to shareholders, a turnaround from profit to loss compared to the previous year.
New Century Medical (01518) announced its annual performance for the year ending on December 31, 2025. The group achieved revenue of approximately 600 million yuan, a decrease of 29.11% compared to the previous year. The company's owners suffered a loss of 115 million yuan, while they made a profit of 47.378 million yuan in the same period last year. The loss per share was 0.24 yuan.
NC HEALTHCARE (01518) announced its annual performance as of December 31, 2025, with the group achieving a revenue of approximately 600 million yuan, a decrease of 29.11% compared to the previous year. The company's shareholders suffered a loss of 115 million yuan, compared to a profit of 47.378 million yuan in the same period last year. The loss per share was 0.24 yuan.
The announcement stated that the group incurred a pre-tax loss of about 74.5 million yuan for the year ending December 31, 2025, compared to a pre-tax profit of about 141.5 million yuan for the year ending December 31, 2024. This was mainly due to a decrease in gross profit of 169 million yuan or 49.0%, as well as an increase in non-current asset impairment losses of 53.7 million yuan.
Related Articles

DATANG ENVIRO (01272) released its annual performance with a net profit of 573 million yuan, a year-on-year increase of 4.44%.

BANK OF GANSU (02139) releases annual performance, net profit increased by 1.1% year-on-year to 590.9 million yuan.

JIA YAO HLDGS(01626) announced that its net profit attributable to owners for the year 2025 is approximately 1.83 million yuan, a decrease of 96.38% compared to the previous year.
DATANG ENVIRO (01272) released its annual performance with a net profit of 573 million yuan, a year-on-year increase of 4.44%.

BANK OF GANSU (02139) releases annual performance, net profit increased by 1.1% year-on-year to 590.9 million yuan.

JIA YAO HLDGS(01626) announced that its net profit attributable to owners for the year 2025 is approximately 1.83 million yuan, a decrease of 96.38% compared to the previous year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


